MYD88 and chronic kidney disease: Ultimately, both experiments in vivo and in vitro confirmed that PCA significantly alleviated inflammation and oxidative stress in the muscles of CKD rats and LPS‐induced C2C12 myoblasts by suppressing the TLR4/MyD88/NF‐κB signalling pathway.